Flavonoid Market by Product type, Form, Application: Global Opportunity Analysis and Industry Forecast, 2021-2030

The global flavonoid market was valued at $1,497.7 million in 2020, and is projected to reach $2,717.8 million by 2030, registering a CAGR of 6.2% from 2021 to 2030.

Flavonoid is one of the category of plant polyphenols which has antioxidant properties. They are majorly responsible for the pigments or colors in vegetables, fruits and flowers. In plants, these colors protect the plants from environmental stress as they are potent with antioxidants. Flavonoid is also industrially manufactured majorly by product types including isoflavones, anthocyanin and others.

Flavonoid is largely used in the nutraceuticals industry. This is attributed to the high consumption and demand for nutraceutical supplements containing flavonoid such as isoflavones and anthocyanin which in turn is driving the growth of the market. In addition, Flavonoid in the pharmaceutical industry is used for It has polyphenolic structure, for that it become responsible for different pharmacological activities. This in turn is also propelling the growth of the market. However, Lack of consumer awareness regarding availability of flavonoid as a dietary supplement is restricting the growth of the market. Nevertheless, Upsurge in the usage of flavonoid in the Food & beverages Industry is likely to offer immense opportunities for the growth of the market during the forecast period.

The global flavonoid market is segmented are categorized into product type, form application and region. By product type, it is classified into isoflavones, anthocyanin and others. By form, the market is bifurcated into powder and liquid. By application, it is divided into pharmaceuticals, nutraceuticals, food & beverages and cosmetics. Region wise, the market is analyzed across North America (the U.S., Canada and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and rest of Europe), Asia-Pacific (China, Japan, India, Australia & New Zealand, South Korea, ASEAN and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, Argentina and Rest of LAMEA).

Some of the major players in the global flavonoid industry analyzed in this report include Archer-Daniels-Midland Company, Artemis International, BASF SE, Eevia Health, Enomark Biotech, Givaudan International SA, Indena S.p.A, Natac , Nexira, and Xi’an Yuensun Biological Technology Co., Ltd.

Key Benefits for Stakeholders

This report provides a quantitative analysis of the current flavonoid market trends, estimations, and dynamics of the global flavonoid market from 2020 to 2030 to identify the prevailing market opportunities.
The key countries in all the major regions are mapped based on their market share.
Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the market segmentation assists in determining the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global industry. Market player positioning segment facilitates benchmarking and provides a clear understanding of the present position of market players.
The report includes the analysis of the regional as well as global market, key players, market segments, end use, and growth strategies.

KEY MARKET SEGMENTS

By Product type

Isoflavones
Anthocyanin
Others

By Form

Powder
Liquid

By Application

Dietary Supplements
Pharmaceuticals
Cosmetics
Food & Beverages

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Russia
Rest of Europe

Asia-Pacific
China
India
Japan
Australia & New Zealand
South Korea
ASEAN
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Argentina
Rest of LAMEA

Frequently Asked Questions about the Global Flavonoid Market

What is the estimated value of the Global Flavonoid Market?

The Global Flavonoid Market was estimated to be valued at $1497.7 million in 2020.

What is the growth rate of the Global Flavonoid Market?

The growth rate of the Global Flavonoid Market is 6.1%, with an estimated value of $2717.8 million by 2030.

What is the forecasted size of the Global Flavonoid Market?

The Global Flavonoid Market is estimated to be worth $2717.8 million by 2030.

Who are the key companies in the Global Flavonoid Market?

Key companies in the Global Flavonoid Market include Archer, Daniels, Midland Company, Artemis International, BASF SE, Eevia Health, Enomark Biotech, Givaudan International SA, Indena S.p.A and Natac.

Report Attribute	Details
No. of Pages	285
Published	October 2021
Forecast Period	2020 - 2030
Estimated Market Value ( USD ) in 2020	$ 1497.7 million
Forecasted Market Value ( USD ) by 2030	$ 2717.8 million
Compound Annual Growth Rate	6.1%
Regions Covered	Global
No. of Companies Mentioned	10

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. COVID-19 impact on flavonoid market
3.5. Value chain Analysis
3.7. Top Impacting Factor
3.8. Parent Market Analysis
3.9. Market dynamics
3.9.1. Drivers
3.9.1.1. Rising adoption of flavonoid in nutraceuticals industry
Flavonoid is largely used in the nutraceuticals industry. This is attributed to the high consumption and demand for nutraceutical supplements containing flavonoid such as isoflavones and anthocyanidins. Flavonoid as a dietary supplement is available in various formats that include capsules, liquid, and chewable tablets. Flavonoid helps to prevent or treat certain heart conditions, diabetes, treat viral infection and other medical conditions. Thus, the aforementioned factors have driven the adoption of flavonoid such as anthocyanidins and isoflavones in the nutraceutical industry in terms of value sales. This in turn his propelling the growth of the overall flavonoid market globally.
3.9.1.2. Rising usage of flavonoid in pharmaceutical industry
3.9.1.3. Growing usage of flavonoid in cosmetic industry
3.9.2. Restraints
3.9.2.1. Lack of consumer awareness regarding availability of flavonoid as a dietary supplement
3.9.2.2. Potential threat of substitution
3.9.3. Opportunities
3.9.3.1. Upsurge in the usage of flavonoid in the Food Industry
3.9.3.2. Introduction of dietary supplements in untapped market

CHAPTER 4: FLAVONOID MARKET, BY PRODUCT TYP

4.1. Overview
4.1.1. Market size and forecast
4.2. Isoflavones
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Anthocyanidins
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Others
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

CHAPTER 5: FLAVONOID MARKET, BY FORM

5.1. Overview
5.1.1. Market size and forecast
5.3. Powder
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast
5.3.3. Market analysis, by country
5.4. Liquid
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast
5.4.3. Market analysis, by country

CHAPTER 6: FLAVONOID MARKET, BY APPLICATION

6.1. Overview
6.1.1. Market size and forecast
6.2. Cosmetics
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast
6.2.3. Market analysis, by country
6.3. Pharmaceuticals
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast
6.3.3. Market analysis, by country
6.4. Nutraceuticals
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast
6.4.3. Market analysis, by country
6.5. Food & Beverages
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast
6.5.3. Market analysis, by country

CHAPTER 7: FLAVONOID MARKET , BY REGION

7.1. Overview
7.1.1. Market size and forecast, by region
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by product type
7.2.3. Market size and forecast, by form
7.2.4. Market size and forecast, by application
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by product type
7.2.5.1.2. Market size and forecast, by form
7.2.5.1.3. Market size and forecast, by application
7.2.5.2. Mexico
7.2.5.2.1. Market size and forecast, by product type
7.2.5.2.2. Market size and forecast, by form
7.2.5.2.3. Market size and forecast, by application
7.2.5.3. Canada
7.2.5.3.1. Market size and forecast, by product type
7.2.5.3.2. Market size and forecast, by form
7.2.5.3.3. Market size and forecast, by application
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by product type
7.3.3. Market size and forecast, by form
7.3.4. Market size and forecast, by application
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by product type
7.3.5.1.2. Market size and forecast, by form
7.3.5.1.3. Market size and forecast, by application
7.3.5.2. UK
7.3.5.2.1. Market size and forecast, by product type
7.3.5.2.2. Market size and forecast, by form
7.3.5.2.3. Market size and forecast, by application
7.3.5.3. France
7.3.5.3.1. Market size and forecast, by product type
7.3.5.3.2. Market size and forecast, by form
7.3.5.3.3. Market size and forecast, by application
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by product type
7.3.5.4.2. Market size and forecast, by form
7.3.5.4.3. Market size and forecast, by application
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by product type
7.3.5.5.2. Market size and forecast, by form
7.3.5.5.3. Market size and forecast, by application
7.3.5.6. Netherlands
7.3.5.6.1. Market size and forecast, by product type
7.3.5.6.2. Market size and forecast, by form
7.3.5.6.3. Market size and forecast, by application
7.3.5.7. Rest of Europe
7.3.5.7.1. Market size and forecast, by product type
7.3.5.7.2. Market size and forecast, by form
7.3.5.7.3. Market size and forecast, by application
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by product type
7.4.3. Market size and forecast, by form
7.4.4. Market size and forecast, by application
7.4.5. Market size and forecast, by country
7.4.5.1. India
7.4.5.1.1. Market size and forecast, by product type
7.4.5.1.2. Market size and forecast, by form
7.4.5.1.3. Market size and forecast, by application
7.4.5.2. Japan
7.4.5.2.1. Market size and forecast, by product type
7.4.5.2.2. Market size and forecast, by form
7.4.5.2.3. Market size and forecast, by application
7.4.5.3. China
7.4.5.3.1. Market size and forecast, by product type
7.4.5.3.2. Market size and forecast, by form
7.4.5.3.3. Market size and forecast, by application
7.4.5.5. Australia
7.4.5.5.1. Market size and forecast, by product type
7.4.5.5.2. Market size and forecast, by form
7.4.5.5.3. Market size and forecast, by application
7.4.5.6. South Korea
7.4.5.6.1. Market size and forecast, by product type
7.4.5.6.2. Market size and forecast, by form
7.4.5.6.3. Market size and forecast, by application
7.4.5.7. Rest of Asia-Pacific
7.4.5.7.1. Market size and forecast, by product type
7.4.5.7.2. Market size and forecast, by form
7.4.5.7.3. Market size and forecast, by application
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by product type
7.5.3. Market size and forecast, by form
7.5.4. Market size and forecast, by application
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by product type
7.5.5.1.2. Market size and forecast, by form
7.5.5.1.3. Market size and forecast, by application
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by product type
7.5.5.2.2. Market size and forecast, by form
7.5.5.2.3. Market size and forecast, by application
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by product type
7.5.5.3.2. Market size and forecast, by form
7.5.5.3.3. Market size and forecast, by application
7.5.5.4. Argentina
7.5.5.4.1. Market size and forecast, by product type
7.5.5.4.2. Market size and forecast, by form
7.5.5.4.3. Market size and forecast, by application
7.5.5.5. Rest of LAMEA
7.5.5.5.1. Market size and forecast, by product type
7.5.5.5.2. Market size and forecast, by form
7.5.5.5.3. Market size and forecast, by application

CHAPTER 8: COMPETITION LANDSCAPE

8.1. Overview
8.2. Competitive dashboard
8.3. Competitive heat map
8.4. Product mapping
8.5. Top winning strategies
8.6. Key developments
8.6.1. Acquisition
8.6.2. Business Expansion
8.6.3. Joint venture
8.6.4. Partnership
8.6.5. Product Launch
8.7. Top Player Positioning

CHAPTER 9: COMPANY PROFILES

9.1. ARCHER DANIELS MIDLAND COMPANY
9.1.1. Company overview
9.1.2. Key executive
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. R&D expenditure
9.1.7. Business performance
9.1.8. Key strategic moves and developments
9.2. ARTEMIS INTERNATIONAL
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Product portfolio
9.2.5. Key strategic moves and developments
9.3. BASF SE
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. EEVIA HEALTH PLC
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Product portfolio
9.4.5. Business performance
9.5. ENOMARK BIOTECH (ENOMARK HEALTHCARE)
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Product portfolio
9.6. Givaudan International SA (NATUREX S.A.)
9.6.1. Company overview
9.6.2. Key executive
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. R&D expenditure
9.6.7. Business performance
9.6.8. Key strategic moves and developments
9.7. INDENA S.P.A.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Product portfolio
9.8. NATAC
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Product portfolio
9.8.5. Key strategic moves and developments
9.9. NEXIRA
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Product portfolio
9.10. XIAN YUENSUN BIOLOGICAL TECHNOLOGY CO., LTD.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Product portfolio

List of Tables

TABLE 01. FLAVONOID MARKET REVENUE, BY FLAVONOID MARKET , 2020-2030 ($ THOUSAND)
TABLE 02. ISOFLAVONES MARKET REVENUE, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 03. ANTHOCYANIDINS FLAVONOID MARKET REVENUE, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 04. OTHERS FLAVONOID MARKET REVENUE, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 05. FLAVONOID MARKET REVENUE, BY FORM 2020-2030 ($ THOUSAND)
TABLE 06. FLAVONOID MARKET REVENUE FROM POWDER, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 07. FLAVONOID MARKET REVENUE FROM LIQUID, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 08. FLAVONOID MARKET REVENUE, BY APPLICATION 2020-2030($ THOUSAND)
TABLE 09. FLAVONOID MARKET REVENUE, BY REGION, 2020-2030($ THOUSAND)
TABLE 10. GLOBAL PHARMACEUTICALS FLAVONOID MARKET REVENUE, BY REGION, 2020-2030($ THOUSAND)
TABLE 11. FLAVONOID MARKET REVENUE FROM NUTRACEUTICALS, BY REGION, 2020-2030($ THOUSAND)
TABLE 12. FLAVONOID MARKET REVENUE FROM FOOD & BEVERAGES, BY REGION, 2020-2030($ THOUSAND)
TABLE 13. FLAVONOID MARKET REVENUE, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 14. NORTH AMERICA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE , 2020-2030 ($ THOUSAND)
TABLE 15. NORTH AMERICA FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 16. NORTH AMERICA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 17. NORTH AMERICA FLAVONOID MARKET REVENUE, BY COUNTRY, 2020-2030 ($ THOUSAND)
TABLE 18. U.S. FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 19. U.S. FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 20. U.S FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 21. MEXICO FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 22. MEXICO FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 23. MEXICO FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 24. CANADA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 25. CANADA FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 26. CANADA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 27. EUROPE FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 28. EUROPE FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 29. EUROPE FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 30. EUROPE FLAVONOID MARKET REVENUE, BY COUNTRY, 2020-2030 ($ THOUSAND)
TABLE 31. GERMANY FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 32. GERMANY FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 33. GERMANY FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 34. UK FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 35. UK FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 36. UK FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 37. FRANCE FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 38. FRANCE FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 39. FRANCE FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 40. ITALY FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 41. ITALY FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 42. ITALY FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 43. SPAIN FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 44. SPAIN FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 45. SPAIN FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 46. NETHERLANDS FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 47. NETHERLANDS FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 48. NETHERLANDS FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 49. REST OF EUROPE FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 50. REST OF EUROPE FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 51. REST OF EUROPE FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 52. ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 53. ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 54. ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 55. ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY COUNTRY, 2020-2030 ($ THOUSAND)
TABLE 56. INDIA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 57. INDIA FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 58. INDIA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 59. JAPAN FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 60. JAPAN FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 61. JAPAN FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 62. CHINA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 63. CHINA FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 64. CHINA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 65. AUSTRALIA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 66. AUSTRALIA FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 67. AUSTRALIA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 68. SOUTH KOREA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 69. SOUTH KOREA FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 70. SOUTH KOREA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 71. REST OF ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 72. REST OF ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 73. REST OF ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 74. LAMEA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 75. LAMEA FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 76. LAMEA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 77. LAMEA FLAVONOID MARKET REVENUE, BY COUNTRY, 2020-2030 ($ THOUSAND)
TABLE 78. BRAZIL FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 79. BRAZIL FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 80. BRAZIL FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 81. SAUDI ARABIA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 82. SAUDI ARABIA FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 83. SAUDI ARABIA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 84. SOUTH AFRICA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 85. SOUTH AFRICA FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 86. SOUTH AFRICA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 87. ARGENTINA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 88. ARGENTINA FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 89. ARGENTINA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 90. REST OF LAMEA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 91. REST OF LAMEA FLAVONOID MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 92. REST OF LAMEA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 93. ARCHER DANIELS MIDLAND COMPANY: KEY EXECUTIVE
TABLE 94. ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT
TABLE 95. ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS
TABLE 96. ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO
TABLE 97. ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 98. ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
TABLE 99. ARTEMIS INTERNATIONAL: KEY EXECUTIVES
TABLE 100. ARTEMIS INTERNATIONAL: COMPANY SNAPSHOT
TABLE 101. ARTEMIS INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 102. BASF SE: KEY EXECUTIVES
TABLE 103. BASF SE: COMPANY SNAPSHOT
TABLE 104. BASF SE: OPERATING SEGMENTS
TABLE 105. BASF SE: PRODUCT PORTFOLIO
TABLE 106. BASF SE: NET SALES, 2018-2020 ($MILLION)
TABLE 107. EEVIA HEALTH PLC: KEY EXECUTIVES
TABLE 108. EEVIA HEALTH PLC: COMPANY SNAPSHOT
TABLE 109. EEVIA HEALTH PLC: PRODUCT PORTFOLIO
TABLE 110. EEVIA HEALTH PLC: NET SALES, 2018-2020 ($MILLION)
TABLE 111. ENOMARK BIOTECH: KEY EXECUTIVES
TABLE 112. ENOMARK BIOTECH: COMPANY SNAPSHOT
TABLE 113. ENOMARK BIOTECH: PRODUCT PORTFOLIO
TABLE 114. GIVAUDANINTERNATIONAL SA: KEY EXECUTIVE
TABLE 115. GIVAUDANINTERNATIONAL SA: COMPANY SNAPSHOT
TABLE 116. GIVAUDANINTERNATIONAL SA: OPERATING SEGMENTS
TABLE 117. GIVAUDANINTERNATIONAL SA: PRODUCT PORTFOLIO
TABLE 118. GIVAUDANINTERNATIONAL SA: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 119. GIVAUDANINTERNATIONAL SA: NET SALES, 2018-2020 ($MILLION)
TABLE 120. INDENA S.P.A.: KEY EXECUTIVES
TABLE 121. INDENA S.P.A.: COMPANY SNAPSHOT
TABLE 122. INDENA S.P.A.: PRODUCT PORTFOLIO
TABLE 123. NATAC: KEY EXECUTIVES
TABLE 124. NATAC: COMPANY SNAPSHOT
TABLE 125. NATAC: PRODUCT PORTFOLIO
TABLE 126. NEXIRA: KEY EXECUTIVES
TABLE 127. NEXIRA: COMPANY SNAPSHOT
TABLE 128. NEXIRA: PRODUCT PORTFOLIO
TABLE 129. XIAN YUENSUN BIOLOGICAL TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
TABLE 130. XIAN YUENSUN BIOLOGICAL TECHNOLOGY CO., LTD.: PRODUCT PORTFOLIO

List of Figures

FIGURE 01. FLAVONOID MARKET SNAPSHOT
FIGURE 02. FLAVONOID MARKET: SEGMENTATION
FIGURE 03. TOP INVESTMENT POCKETS
FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05. HIGH BARGAINING POWER OF BUYER
FIGURE 06. MODERATE THREAT OF SUBSTITUTION
FIGURE 07. HIGH THREAT OF NEW ENTRANTS
FIGURE 08. MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 09. FLAVONOID MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 10. FLAVONOID MARKET : TOP IMPACTING FACTOR
FIGURE 11. FLAVONOID MARKET: PARENT MARKET ANALYSIS
FIGURE 12. FLAVONOID MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13. FLAVONOID MARKET, BY PRODUCT TYPE, 2020 (%)
FIGURE 14. COMPARATIVE MARKET SHARE ANALYSIS OF ISOFLAVONES FLAVONOID MARKET, BY COUNTRY,2020 AND 2030 (%)
FIGURE 15. COMPARATIVE MARKET SHARE ANALYSIS OF ANTHOCYANIDINS FLAVONOID MARKET , BY COUNTRY 2020 AND 2030 (%)
FIGURE 16. COMPARATIVE MARKET SHARE ANALYSIS OF OTHERS FLAVONOID MARKET , BY COUNTRY 2020 AND 2030 (%)
FIGURE 17. FLAVONOID MARKET, BY FORM, 2020 (%)
FIGURE 18. COMPARATIVE MARKET SHARE ANALYSIS OF FLAVONOID MARKET FROM POWDER, BY COUNTRY, 2020 AND 2030 (%)
FIGURE 19. COMPARATIVE MARKET SHARE ANALYSIS OF FLAVONOID MARKET FROM LIQUID, BY COUNTRY,2020 AND 2030 (%)
FIGURE 20. FLAVONOID MARKET, BY APPLICATION, 2020 (%)
FIGURE 21. COMPARATIVE MARKET SHARE ANALYSIS OF FLAVONOID MARKET REVENUE FROM COSMETICS, BY COUNTRY, 2020 AND 2030(%)
FIGURE 22. COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF FLAVONOID MARKET FROM PHARMACEUTICALS, BY COUNTRY, 2020 AND 2030(%)
FIGURE 23. COMPARATIVE L MARKET SHARE ANALYSIS OF FLAVONOID MARKET REVENUE FROM NUTRACEUTICALS, BY COUNTRY, 2020 AND 2030(%)
FIGURE 24. COMPARATIVE MARKET SHARE ANALYSIS OF FLAVONOID MARKET REVENUE FROM FOOD & BEVERAGES, BY COUNTRY, 2020 AND 2030(%)
FIGURE 25. FLAVONOID MARKET, BY REGION, 2020 (%)
FIGURE 26. U.S. FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 27. MEXICO FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 28. CANADA FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 29. GERMANY FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 30. UK FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 31. FRANCE FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 32. ITALY FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 33. SPAIN FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 34. NETHERLANDS FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 35. REST OF EUROPE FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 36. INDIA FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 37. JAPAN FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 38. CHINA FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 39. AUSTRALIA FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 40. SOUTH KOREA FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 41. REST OF ASIA-PACIFIC FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 42. BRAZIL FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 43. SAUDI ARABIA FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 44. SOUTH AFRICA FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 45. ARGENTINA FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 46. REST OF LAMEA FLAVONOID MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 47. COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 48. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 49. PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 50. TOP WINNING STRATEGIES, BY YEAR, 2017-2021*
FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017-2021* (%)
FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY, 2017-2021*
FIGURE 53. PLAYER POSITIONING OF TOP 10 KEY PLAYERS
FIGURE 54. ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 55. ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
FIGURE 56. ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 57. ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 58. BASF SE: NET SALES, 2018-2020 ($MILLION)
FIGURE 59. BASF SE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 60. BASF SE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 61. EEVIA HEALTH PLC: NET SALES, 2018-2020 ($MILLION)
FIGURE 62. GIVAUDANINTERNATIONAL SA: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 63. GIVAUDANINTERNATIONAL SA: NET SALES, 2018-2020 ($MILLION)
FIGURE 64. GIVAUDANINTERNATIONAL SA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 65. GIVAUDANINTERNATIONAL SA: REVENUE SHARE BY REGION, 2020 (%)

Companies Mentioned

Archer-Daniels-Midland Company
Artemis International
BASF SE
Eevia Health
Enomark Biotech
Givaudan International SA
Indena S.p.A
Natac
Nexira
Xi’an Yuensun Biological Technology Co. LTD

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic news articles and other related releases for market evaluation
Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

LOADING...